Scotts Miracle Gro Co
Scotts Miracle-Gro: Analysts’ Ratings after Q4
Scotts Miracle-Gro released its fiscal 2019 fourth-quarter and full-year results on November 6. Its stock has fallen 3.55% since its earnings release.
Do New Jersey Voters Want Marijuana Legalized in 2020?
In November, Democratic lawmakers dropped the bill for legalizing recreational marijuana in New Jersey through the Senate.
Canopy Growth and Cronos Group’s Earnings Next Week
Canopy Growth (CGC) (WEED) and Cronos Group (CRON) are set to release their earnings next week. The cannabis sector has been on a roller coaster this year.
Will IIPR Still Be an Investor Favorite Post Q3 Earnings?
Innovative Industrial Properties (IIPR) is set to report its third-quarter results tomorrow. IIPR stock, up 67.2% year-to-date, has been investor favorite.
What to Expect from IIPR’s Earnings for Q3
Innovative Industrial Properties (IIPR) is scheduled to release its Q3 earnings results on November 6. Find out what cannabis investors can expect.
IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.
IIPR’s Q2 Earnings Call: Key Takeaways for Investors
So far, Innovative Industrial Properties (IIPR) stock has been impressive in 2019. The stock has gained almost 126% year-to-date.
Why IIPR’s Q2 Earnings Came in Strong
Innovative Industrial Properties (IIPR) reported strong earnings results yesterday for the second quarter of 2019. Here’s what drove the results.
SMG: How Do Analysts View This Cannabis Stock?
Scotts Miracle-Gro (SMG) stock surged 14% in July. After SMG reported stellar Q3 earnings on July 31, its stock rose 8.6% after the results.
Is Aphria Eyeing CannTrust’s Assets?
Aphria (APHA) had stellar Q4 earnings results. Its operating metrics significantly improved, turning its bottom line positive.
Miracle-Gro, CannTrust, Emerald Health Stocks Surging
Scotts Miracle-Gro (SMG) reported its earnings this morning. Now SMG is surging alongside CannTrust and Emerald Health stocks. Here’s why.
SMG Stock’s Cannabis Bet Is Paying Off
SMG stock became hot last year with other core cannabis stocks like Canopy Growth (WEED) (CGC), Aurora Cannabis (ACB), and Tilray (TLRY).
Analysts’ Views on ScottsMiracle-Gro Stock
After ScottsMiracle-Gro’s (SMG) series of misses last year, analysts turned bearish on its stock and lowered its price target. Their target was at its lowest in January, at ~$84, but has improved since.
How ScottsMiracle-Gro Is Shaping Up after the Cannabis Boom
SMG’s performance Almost a year ago, ScottsMiracle-Gro (SMG) was one of the hottest cannabis stocks, with many investors hoping for windfall gains. However, things didn’t go as they may have liked. ScottsMiracle-Gro stock fell 36% last year, while other cannabis stocks delivered healthy returns. For example, Canopy Growth (WEED)(CGC) rose ~23%, and Cronos Group (CRON) rose ~33%. However, it’s […]
Scotts Miracle-Gro: Analysts’ Recommendations in February
For Scotts Miracle-Gro, one analyst recommended a “strong buy,” three recommended a “buy,” and three recommended a “hold.”
Supreme Cannabis: Analysts’ Target Price in February
Among cannabis stocks (MJ), Supreme Cannabis (SPRWF) has provided an impressive return of 47% YTD (year-to-date).
Why Green Thumb Industries’ Stock Jumped over 10% Today
Cannabis producer and retailer Green Thumb Industries’ stock (GTII)(GTBIF) surged over 10% this afternoon. Here’s why.
What Do Analysts Think about Scotts Miracle-Gro?
The Scotts Miracle-Gro Company (SMG) has large exposure to the lawn and gardening business in the US.
Scotts Miracle-Gro Explores Opportunities in Cannabis Market
SMG’s partnership with the Flowr Corporation could give it an opportunity to pursue options to enter the cannabis cultivation business.
SMG’s Margin Expectations Could Be Concerning
The Scotts Miracle-Gro Company (SMG) continues to face margin headwinds in the lawn and garden segment.
Will Scotts Miracle-Gro’s Q3 Earnings Be Another Disappointment?
The Scotts Miracle-Gro Company (SMG) is set to announce its third-quarter earnings on July 31 after the market closes.
Our 10, Make That 11, Stocks to Buy Scorecard
Our belief is that you have to be a stock picker today. The Nasdaq (QQQ) is up 8% this year and Dow Jones Industrial Average (DIA) is down 1%.
Canada’s Cannabis Act C-45 Makes Progress in the Senate
On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.
Scorecard Update: 5 Stocks I am Watching in a Turbulent Market
It’s been 2 weeks since Market Realist’s CEO picked 5 stocks he was watching in the turbulent market, so let’s take a look back at how those picks have performance compared with the S&P 500.
What Analysts Expect for Mosaic’s Margins
Sales growth and gross income growth are also expected to trickle down to Mosaic’s (MOS) EBITDA (earnings before interest, tax, depreciation, and amortization) estimates.
Scotts Miracle-Gro to Release Fiscal 2Q18 Results Tomorrow
Scotts Miracle-Gro (SMG) will announce its fiscal 2Q18 earnings before markets open on May 1.
18 Earnings Reports We’re Watching Closely Next Week
Last big week of earnings kicks off with not a lot to show for it in the market The week of April 30 is an exciting one in terms of earnings, and here are 18 companies we will be watching closely: Monday McDonald’s Corporation (NYSE: MCD) – before the market opens – great year last […]
5 Stocks I am Watching in a Turbulent Market
Looking across industries and sectors to gauge where we are as earnings winds down next week.
Analysts’ Targets for Scott Miracle-Gro in April
The mean consensus rating for Scotts Miracle-Gro as of April 12, 2018, is 2.3, which is the same as March.
What Tax Cuts in the US Meant for CF Industries
During 4Q17, CF Industries received a one-time tax benefit of $491.0 million, or $2.09 per share, from the lowered corporate taxes in the US.
MedReleaf’s Analyst Ratings and Price Target
The current consensus mean rating for MedReleaf stood at 1.6 with an overall “buy” recommendation on the stock for the next-12-month period.
What Scotts Miracle-Gro Could Gain from Tax Cuts
SMG said it intends to pass on the benefits from tax savings to its employees by increasing salaries and through other programs.
What Scotts Miracle-Gro Said about Its Cannabis-Focused Business
According to Scotts Miracle-Gro, the Hawthorne segment’s sales fell $12 million in 1Q18, excluding acquisitions.
Why Scotts Miracle-Gro Stock Fell 14% on January 30
On Tuesday, January 30, 2018, Scotts Miracle-Gro (SMG) reported its 1Q18 earnings with a GAAP loss per share of $0.35. The stock took a significant beating and fell 14%.
The Marijuana Ecosystem’s Potential Business Opportunities
Given that legislative approval is the strongest driving factor behind the boost in the marijuana industry, companies have rushed to capitalize on the wave.
Is Investment in the Marijuana Space Picking Up?
In the previous part of this series, we saw that the alcohol industry could expect marijuana legalization for recreational purposes as an extension to their growth strategy.
The Motivation for Recreational Marijuana Consumption
In the previous part of this series, we mainly discussed marijuana in medical applications. In this part, we look at the secondary use of marijuana, recreational use.
Why the Medical Marijuana Industry Is Growing
For something like cryptocurrencies, the legitimacy to the end user is still at a very nascent stage. The use of marijuana falls broadly into two categories: medical and recreational.
How Marijuana Acceptance Is Evolving Globally
It’s fascinating to see how the marijuana landscape around the world has evolved in the last three years. According to Canopy Growth (WEED.TO), Canada, Israel, the Czech Republic, Uruguay, and the Netherlands “established federally legal cannabis access regimes” in 2014.
Must-Knows before Investing in the Marijuana Industry
In our recent series Should You Jump on the Marijuana Bandwagon? we briefly touched upon the marijuana industry from an investment perspective.
The Arrival of Marijuana
The medicinal properties of cannabis could act as a catalyst for investments in the industry, but there are still risks.
Scotts Miracle-Gro: Ratings and Price Target for January
Nine Wall Street analysts are covering Scotts Miracle-Gro, They have a consensus mean rating of 2.3 on the stock with an overall “buy” recommendation as of January 10, 2018.
Monsanto: Earnings Estimates and Target Price
As of December 25, 2017, Monsanto stock was covered by 18 analysts according to Reuters. The current consensus rating on the stock stood at 2.56.
Monsanto’s 1Q18 Earnings: What Analysts Expect
In 1Q18, Wall Street analysts expect that Monsanto will report an EBITDA of $0.55 billion, which will give an EBITDA margin of 19.9%.
Analysts’ Estimates for Monsanto’s Margin Expansion
For 1Q18, Wall Street analysts estimate a gross income of $1.3 billion. On net sales of $2.8 billion, it will translate into a gross margin of 48%.
Monsanto’s 1Q18 Earnings: What to Expect
Monsanto (MON) is set to announce its 1Q18 earnings on January 4, 2018, with an EPS (earnings per share) of $0.42.
Scotts Miracle-Gro: Updates for November 2017
Since Scotts Miracle-Gro’s earnings release, the stock closed ~3.7% lower at $98.6 as of November 10. The stock has returned 4% year-to-date.
FMC: Analysts’ Ratings and Upgrades in November 2017
FMC (FMC) reported its earnings on November 6, 2017. It reported an EPS (earnings per share) of $0.7, which beat analysts’ estimate of $0.63 per share.
What Analysts Expect for Scotts Miracle-Gro’s Earnings Margins
For 4Q17, analysts expect that Scotts Miracle-Gro will report an EBITDA income of $11 million. It would result in an EBITDA margin of 3% during the quarter.
Will Scotts Miracle-Gro’s Margins Expand in 4Q17?
There are expectations for cost optimization, which should improve Scotts Miracle-Gro’s gross margins in 4Q17 and the next four quarters.
What to Expect from Scotts Miracle-Gro’s 4Q17 Earnings
The Scotts Miracle-Gro Company (SMG) is expected to announce its 4Q17 earnings on November 2, 2017. It’s expected to report a loss per share of $0.29.
Weighing Trump’s Tax Rates against Agribusiness Rates
The Trump administration’s latest tax plan was announced on September 27 and has drawn criticism as well as support.
How Analysts’ Earnings Estimates for CMP, SMG, and ICL Have Changed
ScottsMiracle-Gro’s estimated earnings per share were revised down 1.0% from $4.56 to $4.53 for fiscal 2018.
Monsanto-Bayer Deal Completion Will Be Delayed
This week, Bayer stated that it expects the Monsanto (MON) acquisition to be delayed. Bayer asked for an extension to January 22.
What Analysts Think about Compass Minerals International
As of September 18, the consensus mean price target on CMP stood at $69.5 per share, which was about 1.6% lower than the closing price of $70 on the same day.
What Do Analysts Recommend for Scotts Miracle-Gro?
The Scotts Miracle-Gro Company (SMG) saw a sharp increase in its price last year.
Top 10 Agricultural Chemicals Stocks Include Scotts Miracle-Gro
Over the past ten-year period, Scotts Miracle-Gro has risen 193.0% and significantly outperformed the S&P 500 Index’s rise of 69.2% over the same period.
Scotts Miracle-Grow Announced a Higher Dividend
Scotts Miracle-Gro announced a 6% dividend increase to $0.53 per quarter from $0.5 per quarter. It has consistently raised its dividend in the past.
Scotts Miracle-Gro’s Margins Are Expanding
During 3Q17, Scotts Miracle-Gro’s (SMG) margins saw some expansion YoY. The company’s sales growth of 8% helped the margin expansion.
Analyzing Scotts-Miracle Gro’s Sales
During 3Q17, Scotts Miracle-Gro’s overall sales rose 8% YoY (year-over-year) to $1.08 billion from $994 million in 3Q16.
Is Scotts Miracle-Gro Slowing Down?
Scotts Miracle-Gro (SMG) announced its recent earnings on August 1, 2017. The company reported EPS (earnings per share) of $2.53 without adjustments.
Scotts Miracle-Gro: Gross Margins Are Expected to Expand in 3Q17
Wall Street analysts expect gross income of $396 million in 3Q17, which will deliver a gross margin of 37% on 3Q17 sales estimates of $1.06 billion.
Scotts Miracle-Gro: Analysts’ Sales Expectations in 3Q17
Scotts Miracle-Gro’s (SMG) sales growth is expected to stand at 4.4% YoY (year-over-year) in the coming four quarters.
What’s Analysts’ Take on Scotts Miracle-Gro in June 2017?
The Scotts Miracle-Gro Company (SMG) closed at $83.4 on June 9, which was 12.8% lower YTD (year-to-date) and has underperformed the S&P 500 Index (SPY) thus far.
What Analysts Recommend for The Scotts Miracle-Gro Company
The Scotts Miracle-Gro Company (SMG) reported its 1Q17 earnings on May 2, 2017, with earnings per share (or EPS) of $2.78.
Analyzing Scotts Miracle-Gro’s Valuation Multiple
As of April 24, Scotts Miracle-Gro (SMG) was trading at a forward PE multiple of 22.5x. In recent months, Scotts Miracle-Gro’s valuation rose.
What to Expect from Scotts Miracle-Gro’s Margins in 2Q17
For its upcoming 2Q17 earnings, Scotts Miracle-Gro’s EBITDA is estimated to come in at $336 million—flat compared to 2Q16.
Scotts Miracle-Gro’s Gross Margins Will Likely Grow in 2Q17
Over the past 12 years, Scotts Miracle-Gro’s (SMG) gross margins have averaged ~35%. The company’s gross margins have been fairly stable in the past.
Analysts’ Estimates for Scotts Miracle-Gro’s Sales
Sell-side analysts estimate that Scotts Miracle-Gro could report sales of $1.2 million in 2Q17—about 2.8% higher than 2Q16.
Scotts Miracle-Gro: What to Expect from Its 2Q17 Earnings
Scotts Miracle-Gro (SMG) is expected to report its 2Q17 earnings on May 2, 2017, before the market opens. Wall Street analysts estimate EPS of $2.9.
Scotts Miracle-Gro: Analyst Recommendations and Target Prices
Analyst recommendations for Scotts Miracle-Gro (SMG) have trended with earnings estimates, with more analysts recommending a “buy” for the stock.
Scotts Miracle-Gro and Its Rising Valuation
Since July 2016, Scotts Miracle-Gro’s PE ratio has trended higher, trading between 20.0x and 24.0x.
Takeaways from Scotts Miracle-Gro’s EBITDA Estimates
Scotts Miracle-Gro’s (SMG) bold foray into hydroponics and organics is expected to trickle down to the company’s EBITDA.
How Much Could Scotts Miracle-Gro Grow with Cannabis?
In fiscal 2016, Scotts Miracle-Gro sales fell 6.0% year-over-year. Sales in fiscal 2017 are estimated at $3.0 billion, which would be a 7.0% rise from 2016.
Scotts Miracle-Gro: Gross Margins in the Near Term
Analysts estimate that in the next three years, sales numbers for Scotts Miracle-Gro (SMG) will trickle down to gross margins.
How Scotts Miracle-Gro Is Embracing Cannabis
When the use of cannabis was made legal in Colorado in 2012, it opened a window of opportunity for businesses such as Scotts Miracle-Gro.
Why Investors Are Enthusiastic about Scotts Miracle-Gro
Scotts Miracle-Gro has come closer to two main business models—hydroponics and organics— in addition to its core business.
Here’s What’s Driving Scotts Miracle-Gro
There are four drivers that impact Scotts Miracle-Gro’s sales. In 2016, its net sales rose 4.0% YoY (year-over-year). In 2015, they rose 5.8% YoY.
A Must Read in March before Investing in Scotts Miracle-Gro
Scotts Miracle-Gro (SMG) has had an impressive market run lately. If you invested in it five years ago, your investment has doubled.
Is Hydroponics the Next Big Thing for Scotts Miracle-Gro?
Scotts Miracle-Gro’s (SMG) acquisition of Hawthrone Gardening helped the company make a foray into the hydroponics business.
Why Scotts Miracle-Gro’s Sales Rose 27% in 1Q17
Scotts Miracle-Gro (SMG) primarily sells its products in North American and European Union markets.
What Investors Are Paying for Scotts Miracle-Gro
On January 25, Scotts Miracle-Gro was trading at a forward price-to-earnings multiple of 22.5x.
Will Scotts Miracle-Gro’s Free Cash Flow Rise in 2017?
In 1Q17, Wall Street analysts are estimating the company to report -$312 million in free cash flows.
How Much Will Scotts Miracle-Gro Spend in Capex in 1Q17?
For 1Q17, analysts estimate Scotts Miracle-Gro’s capital expenditure to stand at $15.8 million, which would be about 7% of the 1Q17 revenue.
What Analysts Expect for SMG’s 1Q17 Revenue
For 1Q17, Wall Street analysts expect Scotts Miracle-Gro to report $233 million in revenue, which would be a 5.3% decline compared to $246 million in 1Q16.
Analyst Recommendations and Price Target for Scotts Miracle-Gro
As of January 23, 2017, the consensus next 12-month price target for SMG is $97.30 per share. That day, the company closed 2.6% below that price target.
How Has Scotts Miracle-Gro Tracked Analysts’ Price Target?
Stock price The Scotts Miracle-Gro Company’s (SMG) stock has grown from its $19 IPO (initial public offering) in 1992 to $95.90 in December 2016. The company, with $5.7 billion in market capitalization, is followed by several analysts on Wall Street. Upgrades and downgrades by these analysts can affect a stock (XLB) like any other. Let’s look […]
Comparing Scotts Miracle-Gro’s Price-To-Earnings Ratio
Relative valuation Earlier in this series, we discussed The Scotts Miracle-Gro Company’s (SMG) forward PE (price-to-earnings) ratio over a 16-year period. We saw that the company has been recently trading at a PE ratio of 21x, which is a 16-year high. Although the PE ratio is a tool for relative valuation, bear in mind that […]
A Look at Scotts Miracle-Gro’s Price-To-Earnings Ratio
Valuation ratio Valuation ratios are critical as they are tools investors (MOO) use to determine the price they should pay for stock. The PE (price-to-earnings) ratio is often used by investors to determine the value of an investment in companies such as The Scotts Miracle-Gro Company (SMG), Central Garden & Pet (CENT), The Home Depot (HD), […]
Key People at Scotts Miracle-Gro
Jim Hagedorn Jim Hagedorn is the current CEO of The Scotts Miracle-Gro Company (SMG). He is the son of Horace Hagedorn, who founded the Miracle-Gro company. When Scotts and Miracle-Gro merged in 1995, Jim Hagedorn joined as a director of the company. Since then, he has served Scotts Miracle-Gro as chief operating officer, president, and chairman […]
Comparing Scotts Miracle-Gro’s Returns
Returns Investors delay today’s consumption and invest so that they can have more tomorrow. While there are many investment vehicles to help achieve that purpose, investors are attracted to equities or stocks for the possibility of getting better returns. Within equity, the goal is to find the companies that can yield higher returns. In this […]
How Scotts Miracle-Gro’s Products Reach Customers
Selling to customers Earlier, we saw that the United States is a major market for The Scotts Miracle-Gro Company (SMG), accounting for about 82% of the company’s net sales in 2016. To reach customers in the United States, the company sells directly and through distributors and brokers. The company’s products are available at warehouse clubs, […]
Scotts Miracle-Gro’s Sales Focus on Two Regions
SMG’s sales The majority of The Scotts Miracle-Gro Company’s (SMG) sales come from the US market. The company’s Scotts, Miracle-Gro, and Ortho brands command more than half of the market share in the United States. The company also claims that the brand awareness level of these three brands stands at over 80%. Let’s look at […]
Why the US Market Is Key for Scotts Miracle-Gro
SMG’s primary market Earlier, we saw that The Scotts Miracle-Gro Company is present in about 18 countries around the globe and serves customer needs from lawn and gardening to weed and pest control. Despite its presence in several countries, Scotts Miracle-Gro has high stakes in the US market. The company serves the consumer and retail […]
How Scotts Miracle-Gro’s Brands Overlap
Scotts’s products and brands The Scotts Miracle-Gro Company (SMG) sells many products that enable customers to grow and maintain lawns and gardens. Since growing lawns and gardens requires several elements, it’s not unusual that several players serve the market (FXZ). These include Central Garden & Pet (CENT), Spectrum Brands (SPB), and Seabord (SEB). The Scotts […]
Overview: Scotts Miracle-Gro’s Brands in Different Countries
Categories of products The Scotts Miracle-Gro Company (SMG) has several products under its umbrella. In North America, which includes the United States and Canada, the company offers products to lawn and garden markets in the consumer segment. Some of the brand names include Scotts, Turf Builder, Miracle-Gro, Nature’s Care, and Ortho. The company is also […]
How Far Is Scotts Miracle-Gro’s Market Reach?
Beginnings in the United States The Scotts Miracle-Gro Company (SMG) began in the United States and initially focused on reaching out to customers within the country. Today, the company operates in 18 countries and has a market capitalization of $5.8 billion. Scotts Miracle-Gro is present in the United States, Europe, Canada, and the Asia-Pacific region. The […]
Scotts Miracle-Gro’s Century-Old History
The history The Scotts Miracle-Gro Company (SMG) dates back to 1868. Conceived by Orlando McLean Scott, it aimed to give farmers weed-free and clean fields. In 1907, Scott’s son, Dwight, saw an opportunity in lawns playing a role in the American lifestyle. Therefore, the company started selling grass seeds, which replaced lower quality grass starters […]
Company Overview: The Scotts Miracle-Gro Company 2016
The Scotts Miracle-Gro Company (SMG) is easy to miss if you find the lawn and gardening business unexciting. However, this company has returned an impressive 49% YTD (year-to-date), outperforming the S&P 500 (SPY), which has returned 11% so far this year.
SMG’s 12-Month Price Target and Analysts’ Recommendations
Of the ten analysts surveyed by Reuters, five have “strong buy” to “buy” recommendations, four have “hold” recommendations, and one has a “sell” recommendation on SMG.